Sirio Pharma Co., Ltd. (SHE:300791)

China · Delayed Price · Currency is CNY

18.41

+0.72 (4.07%)

Sep 30, 2026, 3:04 PM CST

Market Cap	5.65B -21.8%
Revenue (ttm)	4.27B +0.3%
Net Income	128.34M -61.3%
EPS	0.42 -61.2%
Shares Out	307.02M
PE Ratio	43.47
Forward PE	16.15
Dividend	0.13 (0.71%)
Ex-Dividend Date	Jun 5, 2026

Volume	2,897,640
Open	17.70
Previous Close	17.69
Day's Range	17.70 - 18.53
52-Week Range	15.40 - 26.17
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 26, 2026

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry China, the United States, Europe, and internationally. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; liquids; probiotic balls; tablet and powder products; capsules; and functional beverages for beauty and wellness, gut health, bone and joint health, immune and fertility support, cardiovascular and metabolic health, and healthy ageing. It also offers formulation; technical, and researc... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1993

Employees 2,776

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300791

Full Company Profile

Financial Performance

In 2025, Sirio Pharma's revenue was 4.26 billion, an increase of 1.23% compared to the previous year's 4.21 billion. Earnings were 136.53 million, a decrease of -58.00%.

Financial Statements